China's top pharmaceutical distributor rehearses nationwide logistics for upcoming mass inoculation
By Yang Hui, Published: 2020-12-23 12:21:52
Photo: Yang Hui/GT
Editor's Note:
China's top pharmaceutical distributor Sinopharm Holdings has started a nationwide logistics rehearsal process to prepare for the upcoming "mass use" of COVID-19 vaccines. The Global Times visited the rehearsal site to check out how it is conducting large-scale transport drills across the country. Sinopharm Holdings is affiliated with the Chinese state-owned pharmaceutical giant China National Pharmaceutical Group (Sinopharm Group) which developed two of the front-running inactivated vaccines against the coronavirus in China. The company has started large-scaled manoeuvres to test its capacity and capability in all links of the vaccine mass distribution system covering receiving orders, system scheduling, transporting to warehouses, sorting out batches, and landing to local CDCs or vaccination sites.(Photos: Yang Hui/GT)

Photo: Yang Hui/GT
Photo: Yang Hui/GT
Photo: Yang Hui/GT
Photo: Yang Hui/GT
Photo: Yang Hui/GT
Photo: Yang Hui/GT
Photo: Yang Hui/GT
Photo: Yang Hui/GT
Photo: Yang Hui/GT
Photo: Yang Hui/GT
Photo: Yang Hui/GT
Photo: Yang Hui/GT
Photo: Yang Hui/GT